Studies estimating the lifetime risk of women with the BRCA1 and BRCA2 genetic mutation developing breast cancer may have exaggerated the risk by only looking at high-risk families
Studies estimating the lifetime risk of women with the BRCA1 and BRCA2 genetic mutation developing breast cancer may have exaggerated the risk by only looking at high-risk families